Guide · Corporate actions
What is a rights issue?
The short answer
A rights issue is a company raising fresh capital by offering its existing shareholders the right, but not the obligation, to buy new shares at a price below the market, in proportion to what they already hold. It is not free money and not automatically good or bad. The discount is offset by dilution, so the screen price adjusts down to a lower ex-rights level, and your real decisions are why the company is raising the money and whether you subscribe, sell the right, or let it lapse. Understanding the mechanics is what stops you from being quietly diluted, or from mistaking the discount for a gift.
The word discount does a great deal of misleading work in a rights issue. Offered new shares below the market price, many holders feel they are being handed a bargain and either grab it without thinking or ignore the whole event as noise. Both reactions miss what is actually happening. A rights issue is first a financing decision by the company and then a genuine choice for you, wrapped in a price adjustment that nets the discount against dilution. This guide takes it in order: what a rights issue is and why companies use it, the mechanics of the ratio, the price and the record date, why the discount is not a free lunch, your three choices and the cost of doing nothing, how to read the reason for the raise, how a rights issue differs from a follow-on offer and a bonus issue, and how the process works in India.
What a rights issue is, and why companies use it
A rights issue is a way for a listed company to raise money from the people who already own it, rather than from the public at large. The company creates new shares and offers them first to existing shareholders, in proportion to their current holdings, at a fixed subscription price. This ordering is deliberate and is known as a pre-emptive right: before outsiders are invited in, current owners get the chance to maintain their share of the business. In that sense a rights issue respects the existing shareholder register in a way that a sale to new investors does not.
Companies reach for a rights issue when they need equity capital and want to give existing owners first claim on it. Typical reasons include funding an expansion or an acquisition, reducing debt to strengthen the balance sheet, or shoring up capital after a difficult period. The reason matters enormously, because raising equity to grow a healthy business is a very different signal from raising it repeatedly to cover losses, and the same mechanics can sit on top of either story. Later in this guide, reading that reason is treated as the single most important judgment you make.
Pre-emptive by design. The defining feature of a rights issue is that existing shareholders are offered the new shares first, in proportion to what they hold. That is what separates it from a sale of shares to outside investors: you are given the chance to keep your exact slice of the company before anyone else is allowed to buy in. Whether you use that chance, and at what price, is the decision the rest of this guide is about.
The mechanics: ratio, price, record date, entitlement
Four moving parts define any rights issue, and together they decide exactly what lands in your account. The first is the ratio, written like 1:5, which reads as one new share offered for every five you already hold. The second is the subscription price, the fixed amount you pay per new share, set below the current market price to encourage participation. The third is the record date: you must hold the shares in your demat account on that date to be eligible, and the register is frozen at that moment to decide who receives rights. The fourth is the rights entitlement itself, the tradable instrument that represents your right to subscribe.
Put together with illustrative numbers, the picture is concrete. Suppose the shares trade at about 200 rupees and the company announces a 1:5 rights issue at a subscription price of about 160 rupees. If you hold 500 shares on the record date, you are offered 100 new shares, one for every five, at about 160 rupees each, a right you can exercise, sell, or drop. The figure below shows the two halves of the mechanic: the ratio that sizes your entitlement, and the discount that prices it.
Why the discount is not a free lunch
Here is where most of the misunderstanding lives. Because the new shares are offered below the market price, it is tempting to treat the difference as profit already in hand. It is not, because the company is issuing more shares, and the value of the business is now divided across a larger count. Each existing share therefore represents a slightly smaller slice than before, which is dilution. The discount on the new shares and the dilution of the old ones are two sides of one adjustment, and they very nearly cancel.
The market expresses this through the ex-rights price, a weighted blend of the old market price and the lower subscription price. In the illustration, five old shares at about 200 rupees and one new share at about 160 rupees average to an ex-rights price of about 193 rupees. Your new share, bought at 160, is now marked near 193, an apparent gain; but each of your five old shares slips from 200 toward 193, a matching loss. If you take up your full entitlement, the two offset and your total wealth is roughly unchanged by the mechanics alone. The screen price dropping to the ex-rights level is an adjustment, not the company losing value, exactly as an ex-dividend price falls by the dividend. It is the same accounting that sits behind market capitalisation: more shares at a lower price can leave the total unchanged.
The discount is not a gift. It is handed to you with one hand and taken back through dilution with the other, and the ex-rights price is simply where the two meet.
Your three choices, and the cost of doing nothing
Once the entitlement is in your account, you face a clean three-way choice, and doing nothing is one of the three, not an escape from the decision. You can subscribe, paying the offer price to take up the new shares and keep your proportionate ownership intact. You can renounce, selling the rights entitlement to another investor on the exchange during its trading window, which hands you cash for the right while your stake still falls. Or you can let the entitlement lapse, doing nothing, in which case it typically expires worthless and your ownership is diluted for no return at all.
| Your choice | What happens | When it tends to make sense |
|---|---|---|
| Subscribe (take up the rights) | You pay the subscription price and receive the new shares; your proportionate ownership is preserved and you are not diluted | You want to invest more in the business and are comfortable committing fresh capital at the offer price |
| Renounce (sell the right) | You sell the rights entitlement on the exchange during its window and receive cash; your stake still falls, but the dilution is partly offset by the sale proceeds | You do not want to add capital, but the entitlement has a tradable value you would rather capture than forfeit |
| Let it lapse (do nothing) | The entitlement typically expires worthless; new shares go to others, so your proportionate ownership falls and you receive nothing | Rarely sensible; only if the entitlement has negligible value and selling it is not practical |
| Partial take-up | You subscribe to part of your entitlement and sell or lapse the rest, balancing added capital against cash and dilution | You want some added exposure but not the full amount, or want to fund part of the subscription by selling part of the right |
The table makes the trade-offs explicit, but the general rule is simple: letting a valuable entitlement lapse is almost never the right move, because even if you do not want to add capital, the right itself usually has a market value you can capture by selling. The figure below traces the three branches and the outcome of each, including the quiet cost of the do-nothing path.
Reading the reason: growth or a hole?
If the mechanics net out, what actually decides whether a rights issue is worth joining is the reason behind it. Companies raise equity from their owners for very different motives, and the stated use of proceeds, set out in the offer document, is where you look first. Money raised to fund a profitable expansion, an acquisition that fits, or a genuine reduction of expensive debt is one kind of story. Money raised again and again to plug operating losses or to service borrowings the business cannot support is another, and no discount compensates for putting fresh capital into that second case.
This is a judgment, not a formula, and it is exactly the kind of thinking a disciplined process is built to make routine. Reading the use of proceeds, checking whether the raise fits the business, and separating a mechanical price adjustment from a real change in value are habits, and they are the sort of habits that the method we teach is designed to install. Because a rights issue is fundamentally an investment decision rather than a quick trade, it also rewards the longer-horizon mindset discussed in trading versus investing: you are deciding whether to own more of a business, not whether to catch a move.
A discount is not a reason. The single most common mistake is to subscribe because the shares look cheap against the market price. That discount is offset by dilution and tells you nothing about whether the business deserves more of your capital. A deep discount attached to a company raising money to cover losses is not a bargain, it is a larger stake in a weaker balance sheet. Decide on the reason and the business first, and treat the discount as a mechanic, never as the case for investing.
Rights issue versus a follow-on offer and a bonus issue
It helps to place a rights issue next to the corporate actions it is most often confused with. A follow-on public offer also raises fresh capital, but it sells the new shares to the public at large rather than reserving them for existing holders, so a rights issue is really the pre-emptive version that offers you first refusal. An initial public offering is the first such sale a company ever makes; a follow-on offer and a rights issue are what can follow once it is already listed. All three bring in cash and create new shares.
A bonus issue and a stock split are a different species entirely, because no money changes hands and no capital is raised. A bonus issue converts the company reserves into free new shares handed to existing holders; a split simply divides each share into several smaller ones. In both, your share count rises and the price adjusts down so your total value is unchanged, which is why neither dilutes you. The table sets the three side by side.
| The corporate action | What changes | Effect on your holding |
|---|---|---|
| Rights issue | New shares are offered for sale to existing holders at a discount; the company raises cash, and the total share count rises if the offer is taken up | You pay a subscription price to keep your stake; if you do nothing you are diluted and your ownership percentage falls |
| Bonus issue | The company converts its reserves into free new shares and gives them to holders in a set ratio; no cash is raised | Your share count rises and the price adjusts down; your total value is unchanged and there is no dilution |
| Stock split | Each share is divided into more shares of smaller face value; nothing is raised and the reserves are untouched | Your share count rises and the price falls proportionally; your total value is unchanged |
The one line to carry away is that only a rights issue asks you for cash and is therefore a real investment decision. A bonus and a split rearrange what you already own; a rights issue invites you to own more, at a price, with the discount offset by dilution. Confusing the free rearrangements with the paid decision is how people either overvalue a bonus or misread a rights issue as free.
How a rights issue works in India
In India the process runs under the Securities and Exchange Board of India, whose Issue of Capital and Disclosure Requirements Regulations set the disclosures and the timeline so shareholders can make an informed choice. The company announces the record date; if you hold the shares in demat on that date, the rights entitlement is credited to your account as a separate, tradable line. During the offer window you can subscribe and pay, usually through the online rights platform that your bank or brokerage app supports, or you can act on the entitlement directly.
The Indian market makes the renounce option concrete through rights entitlement trading. The entitlement is credited to your demat account and can be bought and sold on the exchange during a short window before the offer closes, settled in dematerialised form, so renouncing is a real, liquid choice rather than a paperwork exercise. On the first day of trading, the entitlement is priced off the difference between the share price and the subscription price, and it then trades on its own. In recent years the regulator has also moved to compress the rights-issue timeline, so the whole process now completes far faster than it once did.
Eligibility hinges on the record date. To receive a rights entitlement you must hold the shares in your demat account on the record date, which means buying in time for settlement to complete before it. Miss the record date and you are not eligible; hold on it and the entitlement appears as a separate instrument you can subscribe to or sell. If you plan to renounce, watch the entitlement trading window closely, because it is short, and the value left in an unused right is exactly what you forfeit by doing nothing.
Common Questions
Frequently Asked Questions
What is a rights issue in simple terms?
+A rights issue is an offer from a listed company to its existing shareholders to buy new shares at a set price, usually below the current market price, in proportion to the shares they already hold. It is a way for the company to raise fresh capital from the people who already own it, rather than from the public at large. The offer arrives as a ratio, such as one new share for every five held, and it is a right rather than an obligation, so you choose whether to act. You can take up the shares, sell the right to someone else, or let it lapse. Because new shares are created, the discounted price is not a simple gift, a point the rest of this guide works through.
Is a rights issue free money because the shares are discounted?
+No. The discount looks like free money but is offset by dilution, because issuing new shares spreads the company value across a larger number of shares. After the offer the price typically settles to a lower ex-rights level that blends the old market price with the cheaper subscription price. The gain on the new share you buy at a discount is matched by a small fall in the value of each old share you already held, so if you take up your full entitlement your total wealth is roughly unchanged by the mechanics alone. What you are really deciding is whether to commit more capital to the business, not whether to collect a discount.
What is the ex-rights price and why does the share price fall?
+The ex-rights price is the theoretical price of the share after the rights issue, once the new discounted shares are taken into account. It is a weighted blend of the old market price and the lower subscription price, so it sits below the pre-issue market price. The screen price falling to this level is a mechanical adjustment, not the company losing value, in the same way an ex-dividend price drops by the dividend. A lower price after a rights issue can therefore be misleading if read in isolation. Understanding this stops you from mistaking a normal adjustment for a real loss.
What are my choices in a rights issue?
+You have three. You can subscribe, paying the offer price to buy the new shares, which keeps your proportionate ownership intact. You can renounce, selling your rights entitlement to another investor on the exchange during the trading window, which returns some value in cash while your stake still falls. Or you can let the entitlement lapse by doing nothing, in which case you usually receive nothing and your ownership percentage shrinks. The right choice depends on whether you want to invest more, and on the market price of the rights entitlement relative to the discount on offer.
What happens if I do nothing in a rights issue?
+Doing nothing is itself a decision, and usually the worst of the three. If you neither subscribe nor sell your rights entitlement, it typically lapses and you receive nothing for it. Meanwhile new shares are issued to those who did participate, so your proportionate ownership in the company falls, which is dilution. You lose both the value the right itself could have been sold for and part of your share of the business. Because the entitlement often has a tradable value, letting it lapse tends to leave money on the table for no reason.
Can I sell my rights entitlement in India?
+In most Indian rights issues, yes. The rights entitlement is credited to your demat account and can be traded on the exchange during a short window before the offer closes. This lets you renounce, selling the right to another investor for cash, instead of subscribing. Settlement is in dematerialised form and follows the exchange timeline. If you do not want to put in more money, selling the entitlement is usually far better than letting it lapse for nothing.
How is a rights issue different from a bonus issue?
+A rights issue raises money: you pay a subscription price to buy new shares, and the company receives fresh capital. A bonus issue raises nothing: the company simply converts its reserves into new shares and gives them to existing holders for free, in a set ratio. In a bonus issue and a stock split your number of shares rises while the price adjusts down, so your total value is unchanged and no cash changes hands. A rights issue is different because it asks for cash and is a genuine investment decision. The shared idea is that in each case the price adjusts so the corporate action is not free value appearing from nowhere.
Is a rights issue good or bad for shareholders?
+Neither by default. It depends on why the company is raising money and on the terms of the offer. Capital raised to fund profitable growth is very different from capital raised repeatedly to cover losses or service debt, and the stated use of proceeds is where you look first. A deep discount is not a reason to participate on its own, because the discount is offset by dilution. Read the reason, weigh whether you want more exposure to this business, and treat the discount as a mechanic rather than a bargain.
Where the facts come from
Sources
- The regulatory framework. The Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, govern rights issues in Chapter III, setting the disclosures, pricing framework and timeline. sebi.gov.in
- Rights entitlement trading. The National Stock Exchange of India FAQs on Rights Entitlement Trading describe how the entitlement is credited to demat, traded on the exchange during the window, and settled in dematerialised form. nseindia.com
- Faster rights issues. The Securities and Exchange Board of India has moved to compress the rights-issue completion timeline, the basis for the note that the process now finishes far faster than before. sebi.gov.in
- Dilution and the ex-rights price. Richard A. Brealey, Stewart C. Myers and Franklin Allen, Principles of Corporate Finance, sets out how a rights issue dilutes existing shares and how the theoretical ex-rights price is computed as a weighted blend.
- Illustrative figures only. The rupee amounts, the 1:5 ratio and the ex-rights arithmetic in this guide are illustrative and chosen to explain the mechanics; they are not a current specification and no specific company is named.
Educational note. This guide explains how a rights issue works and how to think about participating. It is not a recommendation to buy, sell, subscribe or renounce in any specific offer, it makes no claim about returns, and it is not investment advice. Equity carries the full risk of the market, including the possible loss of capital. Bharath Shiksha is an educational publisher, not a SEBI-registered investment adviser or research analyst.